IMMUNOCELLULAR THERAPEUTICS shareholder history

Current and past IMMUNOCELLULAR THERAPEUTICS shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
Anson Funds Management LP 110.12%0.12%0.12%Q3 2016Q3 20161
SABBY MANAGEMENT, LLC 110.04%0.04%0.04%Q3 2016Q3 20161
UBS Group AG 110.00%0.00%0.00%Q3 2016Q3 20161
External links

This page lists all the filers that currently own IMMUNOCELLULAR THERAPEUTICS or have owned IMMUNOCELLULAR THERAPEUTICS in the past.